{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:21:19Z","timestamp":1787923279331,"version":"build-2784847793"},"reference-count":75,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:00:00Z","timestamp":1787875200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Gastric cancer remains a major cause of cancer mortality worldwide, mainly due to its frequent diagnosis at advanced stages and the high probability of recurrence even after curative treatment. Conventional postoperative follow-up is mainly based on imaging studies, endoscopy and serological tumor markers, such as carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), and carbohydrate antigen 72-4 (CA72-4)This narrative review was based on a structured literature search of PubMed, Scopus, Web of Science, MEDLINE, the Cochrane Library, and ClinicalTrials.gov from database inception through June 2026, with 75 studies included in the final narrative synthesis. Among these analytes, circulating tumor DNA (ctDNA)currently provides the most mature data for the detection of molecular residual disease and postoperative risk stratification. Although it allows for the early detection of recurrent or residual disease prior to imaging confirmation, postoperative ctDNA has shown significant prognostic value in many studies; however, routine use as a basis for decision-making in treatment planning is still considered investigational and will require future prospective clinical validation. Tumor-informed ctDNA approaches offer high analytical specificity and sensitivity in low-burden disease settings. In contrast, tumor-agnostic approaches, such as methylation analysis and fragmentomics, may improve the scalability of the method. However, they require further validation in the postoperative setting. At the same time, emerging data indicate that extracellular vesicles, exosomal RNA and peritoneal lavage analytes can provide complementary biological information, especially in cases of peritoneal dissemination. Despite the significant prospects, the use of liquid biopsy in guiding the treatment of gastric cancer remains under investigation. This is because even today there are limitations. Characteristic are the low ctDNA excretion and the anatomical heterogeneity of the disease, as well as clonal hematopoiesis. Limitations also include the lack of standardization as well as the cost and the need for prospective clinical studies. This review summarizes the biological basis of molecular residual disease, liquid biopsy technologies, ctDNA data, the concept of molecular recurrence, and the future prospects of multi-analytic and artificial intelligence (AI)-assisted surveillance models in gastric cancer.<\/jats:p>","DOI":"10.3390\/ijms27177697","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:27:46Z","timestamp":1787920066000},"page":"7697","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Liquid Biopsy for Molecular Residual Disease Detection and Postoperative Surveillance in Gastric Cancer: Current Evidence and Future Directions"],"prefix":"10.3390","volume":"27","author":[{"given":"Lydia","family":"Lazaridou","sequence":"first","affiliation":[{"name":"Department of General Surgery, University Hospital of Larissa, 41110 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalliopi","family":"Vakalou","sequence":"additional","affiliation":[{"name":"Department of General Surgery, University Hospital of Larissa, 41110 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Dimaki","sequence":"additional","affiliation":[{"name":"Department of General Surgery, University Hospital of Larissa, 41110 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5614-4770","authenticated-orcid":false,"given":"Konstantinos Eleftherios","family":"Koumarelas","sequence":"additional","affiliation":[{"name":"Department of General and Orthopaedic Surgery, Spitalverbund Appenzell Ausserrhoden, 9100 Herisau, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Zachos","sequence":"additional","affiliation":[{"name":"Department of General Surgery, University Hospital of Larissa, 41110 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7046-0112","authenticated-orcid":false,"given":"Dimitrios","family":"Schizas","sequence":"additional","affiliation":[{"name":"Department of First Surgery, National and Kapodistrian University of Athens, 11527 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grigorios","family":"Christodoulidis","sequence":"additional","affiliation":[{"name":"Department of General Surgery, University Hospital of Larissa, 41110 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.3748\/wjg.v30.i12.1680","article-title":"Liquid biopsy for gastric cancer: Techniques, applications, and future directions","volume":"30","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Mondal, D., Shinde, S., Sinha, V., Dixit, V., Paul, S., Gupta, R.K., Thakur, S., Vishvakarma, N.K., and Shukla, D. (2024). Prospects of liquid biopsy in the prognosis and clinical management of gastrointestinal cancers. Front. Mol. Biosci., 11.","DOI":"10.3389\/fmolb.2024.1385238"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"11772719221141525","DOI":"10.1177\/11772719221141525","article-title":"Advantages and Limitations of Monitoring Circulating Tumor DNA Levels to Predict the Prognosis of Patients Diagnosed With Gastric Cancer","volume":"17","author":"He","year":"2022","journal-title":"Biomark. Insights"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1038\/s44321-024-00169-0","article-title":"Diagnosis and prognosis prediction of gastric cancer by high-performance serum lipidome fingerprints","volume":"16","author":"Cai","year":"2024","journal-title":"EMBO Mol. Med."},{"key":"ref_5","first-page":"101886","article-title":"Advancements in non-invasive diagnosis of gastric cancer","volume":"31","author":"Wang","year":"2025","journal-title":"World J. Gastroenterol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s11658-024-00676-5","article-title":"Exosome-derived proteins in gastric cancer progression, drug resistance, and immune response","volume":"29","author":"Wang","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Grizzi, G., Salati, M., Bonomi, M., Ratti, M., Holladay, L., De Grandis, M.C., Spada, D., Baiocchi, G.L., and Ghidini, M. (2023). Circulating Tumor DNA in Gastric Adenocarcinoma: Future Clinical Applications and Perspectives. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24119421"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/cac2.12494","article-title":"Residual circulating tumor DNA after adjuvant chemotherapy effectively predicts recurrence of stage II\u2013III gastric cancer","volume":"43","author":"Yuan","year":"2023","journal-title":"Cancer Commun."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3349\/ymj.2023.0096","article-title":"Monitoring the Outcomes of Systemic Chemotherapy Including Immune Checkpoint Inhibitor for HER2-Positive Metastatic Gastric Cancer by Liquid Biopsy","volume":"64","author":"Jung","year":"2023","journal-title":"Yonsei Med. J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e36228","DOI":"10.1097\/MD.0000000000036228","article-title":"Circulating tumor DNA predicts recurrence and assesses prognosis in operable gastric cancer: A systematic review and meta-analysis","volume":"102","author":"Mi","year":"2023","journal-title":"Medicine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"16687","DOI":"10.1002\/cam4.6286","article-title":"Monitoring of gastrointestinal carcinoma via molecular residual disease with circulating tumor DNA using a tumor-informed assay","volume":"12","author":"Qi","year":"2023","journal-title":"Cancer Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/s41591-024-02877-z","article-title":"Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal\/gastroesophageal junction cancer: A phase Ib trial and ctDNA analyses","volume":"30","author":"Kelly","year":"2024","journal-title":"Nat. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s13258-023-01412-7","article-title":"Postoperative circulating tumor DNA detection and CBLB mutations are prognostic biomarkers for gastric cancer","volume":"45","author":"Zhou","year":"2023","journal-title":"Genes Genom."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Mencel, J., Slater, S., Cartwright, E., and Starling, N. (2022). The Role of ctDNA in Gastric Cancer. Cancers, 14.","DOI":"10.3390\/cancers14205105"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"30739","DOI":"10.1038\/s41598-024-79252-y","article-title":"Extensive methylation analysis of circulating tumor DNA in plasma of patients with gastric cancer","volume":"14","author":"Nagano","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Ma, X., Ou, K., Liu, X., and Yang, L. (2022). Application progress of liquid biopsy in gastric cancer. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.969866"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"101281","DOI":"10.1016\/j.xcrm.2023.101281","article-title":"Cell-free multi-omics analysis reveals potential biomarkers in gastrointestinal cancer patients\u2019 blood","volume":"4","author":"Tao","year":"2023","journal-title":"Cell Rep. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"RP89083","DOI":"10.7554\/eLife.89083.3","article-title":"Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization","volume":"12","author":"Nguyen","year":"2023","journal-title":"eLife"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e2200420","DOI":"10.1200\/PO.22.00420","article-title":"Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers","volume":"6","author":"Huffman","year":"2022","journal-title":"JCO Precis. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13046-024-03269-4","article-title":"Gastric cancer-derived exosomal let-7 g-5p mediated by SERPINE1 promotes macrophage M2 polarization and gastric cancer progression","volume":"44","author":"Ye","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"217758","DOI":"10.1016\/j.canlet.2025.217758","article-title":"Exosomal Biglycan promotes gastric cancer progression via M2 polarization and CXCL10-mediated JAK\/STAT1 activation","volume":"626","author":"Li","year":"2025","journal-title":"Cancer Lett."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1186\/s12967-024-05611-y","article-title":"The expansion of MDSCs induced by exosomal PD-L1 promotes the progression of gastric cancer","volume":"22","author":"Li","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"eadj9283","DOI":"10.1126\/scitranslmed.adj9283","article-title":"Genome-wide repeat landscapes in cancer and cell-free DNA","volume":"16","author":"Annapragada","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41467-023-44461-y","article-title":"Terminal modifications independent cell-free RNA sequencing enables sensitive early cancer detection and classification","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e083659","DOI":"10.1136\/bmjopen-2023-083659","article-title":"Effectiveness of peritoneal lavage fluid circulating tumour cells and circulating tumour DNA in the prediction of metachronous peritoneal metastasis of gastric cancer (pT4NxM0\/pT1-3N+M0) after radical resection: Protocol of a prospective single-centre clinical study","volume":"14","author":"Bai","year":"2024","journal-title":"BMJ Open"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/1354750X.2023.2201664","article-title":"Utilizing circulating tumour DNA as a prognostic predictor of gastric cancer: A meta-analysis","volume":"28","author":"Min","year":"2023","journal-title":"Biomarkers"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.3390\/curroncol29030120","article-title":"Circulating Tumor DNA in Gastric and Gastroesophageal Junction Cancer","volume":"29","author":"Paschold","year":"2022","journal-title":"Curr. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"473","DOI":"10.5306\/wjco.v13.i6.473","article-title":"Circulating tumor DNA for diagnosis, prognosis and treatment of gastrointestinal malignancies","volume":"13","author":"Kirchweger","year":"2022","journal-title":"World J. Clin. Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Safiejko, K., Juchimiuk, M., Pierko, J., Maslyk, M., Mucha, M., Koda, M., Konczuga-Koda, L., Radej, S., Akcakaya, A., and Szarpak, L. (2026). Liquid Biopsy in Gastrointestinal Cancers: Circulating Tumor DNA for Molecular Residual Disease Assessment and Early Treatment Monitoring. Cancers, 18.","DOI":"10.3390\/cancers18061014"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e2400288","DOI":"10.1200\/PO.24.00288","article-title":"Circulating Tumor DNA as a Prognostic Biomarker for Recurrence in Patients With Locoregional Esophagogastric Cancers With a Pathologic Complete Response","volume":"8","author":"Lander","year":"2024","journal-title":"JCO Precis. Oncol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.21873\/anticanres.16367","article-title":"Tumor DNA in Peritoneal Lavage as a Novel Biomarker for Predicting Peritoneal Recurrence in Patients With Gastric Cancer","volume":"43","author":"Yukawa","year":"2023","journal-title":"Anticancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41419-025-07749-z","article-title":"Tumor exosomal circPTBP3 drives gastric cancer peritoneal metastasis via mesothelial-mesenchymal transition","volume":"16","author":"Dong","year":"2025","journal-title":"Cell Death Dis."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Satala, C.B., Gurau, A.M., Mihalache, D., Patrichi, G., Mehedinti, R.C., Leibovici, A.R., and Gur\u0103u, G. (2026). From Primary Tumor to Peritoneal Niche: Microenvironmental Divergence in Gastric Cancer Peritoneal Metastasis. Cells, 15.","DOI":"10.3390\/cells15121055"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e2309298","DOI":"10.1002\/advs.202309298","article-title":"M2 Tumor-Associated Macrophages-Derived Exosomal MALAT1 Promotes Glycolysis and Gastric Cancer Progression","volume":"11","author":"Wang","year":"2024","journal-title":"Adv. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.trsl.2025.08.003","article-title":"Effectiveness of circulating tumor cells and circulating tumor DNA in peritoneal lavage fluid for predicting metachronous peritoneal metastasis of gastric cancer","volume":"283","author":"Bai","year":"2025","journal-title":"Transl. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1002\/ijc.70233","article-title":"Peritoneal lavage fluid minimal residual cancer cells detection for early prediction of peritoneal metastasis in gastric cancer: A multi-cohort validation study","volume":"158","author":"Yue","year":"2026","journal-title":"Int. J. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.3748\/wjg.v29.i17.2515","article-title":"Novel biomarkers for early detection of gastric cancer","volume":"29","author":"Matsuoka","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1055\/s-0043-1771193","article-title":"BL-MOL-AR Project, Preliminary Results about Liquid Biopsy: Molecular Approach Experience and Research Activity in Oncological Settings","volume":"10","author":"Pancrazzi","year":"2023","journal-title":"Glob. Med. Genet."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1200\/JCO.23.02626","article-title":"Trastuzumab Deruxtecan in Advanced Solid Tumors With Human Epidermal Growth Factor Receptor 2 Amplification Identified by Plasma Cell-Free DNA Testing: A Multicenter, Single-Arm, Phase II Basket Trial","volume":"42","author":"Yagisawa","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"6833","DOI":"10.1038\/s41467-024-51271-3","article-title":"Clinical outcomes and ctDNA correlates for CAPOX BETR: A phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma","volume":"15","author":"Singh","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e1791","DOI":"10.1002\/wrna.1791","article-title":"Cell-free RNA for the liquid biopsy of gastrointestinal cancer","volume":"14","author":"Xing","year":"2023","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00535-022-01879-3","article-title":"Gastric cancer and genomics: Review of literature","volume":"57","author":"Onoyama","year":"2022","journal-title":"J. Gastroenterol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Satala, C.B., Jung, I., and Gurzu, S. (2023). Mucin-Phenotype and Expression of the Protein V-Set and Immunoglobulin Domain Containing 1 (VSIG1): New Insights into Gastric Carcinogenesis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24108697"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3892\/ol.2023.14009","article-title":"Extracellular vesicle biomarkers in circulation for the diagnosis of gastric cancer: A systematic review and meta-analysis","volume":"26","author":"Xue","year":"2023","journal-title":"Oncol. Lett."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1038\/s41591-024-02992-x","article-title":"Trastuzumab deruxtecan in HER2-positive advanced gastric cancer: Exploratory biomarker analysis of the randomized, phase 2 DESTINY-Gastric01 trial","volume":"30","author":"Shitara","year":"2024","journal-title":"Nat. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12943-025-02367-x","article-title":"GUIDE: A prospective cohort study for blood-based early detection of gastrointestinal cancers using targeted DNA methylation and fragmentomics sequencing","volume":"24","author":"Huang","year":"2025","journal-title":"Mol. Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"17588359231225038","DOI":"10.1177\/17588359231225038","article-title":"Analysis of circulating tumor DNA identifies distinct therapeutic response to intraperitoneal and intravenous paclitaxel plus S-1 in gastric cancer patients with peritoneal metastasis","volume":"16","author":"Yuan","year":"2024","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/clinchem\/hvab204","article-title":"Genome-Scale Methylation Analysis of Circulating Cell-Free DNA in Gastric Cancer Patients","volume":"68","author":"Ren","year":"2022","journal-title":"Clin. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"17588359231183678","DOI":"10.1177\/17588359231183678","article-title":"Association between circulating tumor cells in the peripheral blood and the prognosis of gastric cancer patients: A meta-analysis","volume":"15","author":"Jin","year":"2023","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e00561","DOI":"10.14309\/ctg.0000000000000561","article-title":"A Novel Nomogram to Predict Resectable Gastric Cancer Based on Preoperative Circulating Tumor Cell","volume":"15","author":"Xia","year":"2024","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5230\/jgc.2024.24.e5","article-title":"Liquid Biopsy: An Emerging Diagnostic, Prognostic, and Predictive Tool in Gastric Cancer","volume":"24","author":"Han","year":"2024","journal-title":"J. Gastric Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12943-024-02116-6","article-title":"Exosomal miR-4745-5p\/3911 from N2-polarized tumor-associated neutrophils promotes gastric cancer metastasis by regulating SLIT2","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/JS9.0000000000000249","article-title":"Early assessment of circulating exosomal lncRNA-GC1 for monitoring neoadjuvant chemotherapy response in gastric cancer","volume":"109","author":"Guo","year":"2023","journal-title":"Int. J. Surg."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/s41467-023-37403-1","article-title":"Single test-based diagnosis of multiple cancer types using Exosome-SERS-AI for early stage cancers","volume":"14","author":"Shin","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.7150\/jca.92704","article-title":"Cell-free Nucleic Acid as Promising Diagnostic Biomarkers for Gastric Cancer: A Systematic Review","volume":"15","author":"Zhang","year":"2024","journal-title":"J. Cancer"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12943-024-01966-4","article-title":"Exosome circATP8A1 induces macrophage M2 polarization by regulating the miR-1-3p\/STAT6 axis to promote gastric cancer progression","volume":"23","author":"Deng","year":"2024","journal-title":"Mol. Cancer"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12935-023-02976-w","article-title":"Exosomal hsa_circ_000200 as a potential biomarker and metastasis enhancer of gastric cancer via miR-4659a\/b-3p\/HBEGF axis","volume":"23","author":"Huang","year":"2023","journal-title":"Cancer Cell Int."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13045-025-01689-z","article-title":"Non-canonical small noncoding RNAs in the plasma extracellular vesicles as novel biomarkers in gastric cancer","volume":"18","author":"Yang","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e21916","DOI":"10.1096\/fj.202100294RR","article-title":"Expression, regulation, and function of exosome-derived miRNAs in cancer progression and therapy","volume":"35","author":"Li","year":"2021","journal-title":"FASEB J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/s41416-022-02138-1","article-title":"A liquid biopsy signature for predicting early recurrence in patients with gastric cancer","volume":"128","author":"Okuno","year":"2023","journal-title":"Br. J. Cancer"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"45","DOI":"10.14216\/kjco.23009","article-title":"Concordance of circulating tumor DNA and matched formalin-fixed paraffin-embedded tumor tissue in gastric cancer as a predictor of recurrence","volume":"19","author":"Seo","year":"2023","journal-title":"Korean J. Clin. Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Palieri, R., De Luca, M., Balestra, F., Panzetta, G., Lotesoriere, C., Rizzi, F., Ricci, A.D., Mastrogiacomo, R., Curri, M.L., and Laghi, L.A. (2025). Liquid biopsy in gastrointestinal oncology: Clinical applications and translational integration of ctDNA, CTCs, and sEVs. Oncol. Rev., 19.","DOI":"10.3389\/or.2025.1702932"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Dadgar, N., Anees, M., Sherry, C., Park, H.Y., Grayhack, E.E., Goel, A., Khan, A.F., Omstead, A., Bartlett, D.L., and Wagner, P.L. (2025). Blood-Based Surveillance Biomarkers for Gastroesophageal Cancers. Cancers, 17.","DOI":"10.3390\/cancers17213552"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"6815","DOI":"10.1038\/s41467-025-62056-7","article-title":"Longitudinal circulating tumor DNA analysis during treatment of locally advanced resectable gastric or gastroesophageal junction adenocarcinoma: The PLAGAST prospective biomarker study","volume":"16","author":"Zaanan","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Bian, J., and Liu, J. (2026). Circulating tumor DNA and prognosis in gastric cancer patients undergoing surgery: Meta-analysis and trial sequential analysis. Front. Oncol., 16.","DOI":"10.3389\/fonc.2026.1774979"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41419-020-2531-z","article-title":"Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer","volume":"11","author":"Yang","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_67","first-page":"1","article-title":"Monitoring circulating tumor DNA by analyzing personalized cancer-specific rearrangements to detect recurrence in gastric cancer","volume":"51","author":"Kim","year":"2019","journal-title":"Exp. Mol. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s13402-026-01218-1","article-title":"Precision oncology in gastric cancer: Navigating molecular subtypes, therapeutic targets, and future horizons","volume":"49","author":"Hong","year":"2026","journal-title":"Cell. Oncol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/s41419-022-05350-2","article-title":"Liquid biopsy in gastric cancer: Predictive and prognostic biomarkers","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41698-025-00875-z","article-title":"Non-invasive liquid biopsy based on transcriptomic profiling for early diagnosis of occult peritoneal metastases in locally advanced gastric cancer","volume":"9","author":"Ding","year":"2025","journal-title":"npj Precis. Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Chen, Y., Zhang, J., Han, G., Tang, J., Guo, F., Li, W., Xie, L., Xu, H., Zhang, X., and Tian, Y. (2023). Efficacy and safety of XELOX combined with anlotinib and penpulimab vs XELOX as an adjuvant therapy for ctDNA-positive gastric and gastroesophageal junction adenocarcinoma: A protocol for a randomized, controlled, multicenter phase II clinical trial (EXPLORING study). Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1232858"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"7098","DOI":"10.1158\/1078-0432.CCR-19-1704","article-title":"Circulating Tumor DNA Sequencing Analysis of Gastroesophageal Adenocarcinoma","volume":"25","author":"Maron","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12967-023-04077-8","article-title":"Genomic alterations of cerebrospinal fluid cell-free DNA in leptomeningeal metastases of gastric cancer","volume":"21","author":"Chen","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Jelski, W., and Mroczko, B. (2022). Molecular and Circulating Biomarkers of Gastric Cancer. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23147588"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Glyn, T., and Purcell, R. (2022). Circulating Bacterial DNA: A New Paradigm for Cancer Diagnostics. Front. Med., 9.","DOI":"10.3389\/fmed.2022.831096"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7697\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:29:22Z","timestamp":1787920162000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/17\/7697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,28]]},"references-count":75,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ijms27177697"],"URL":"https:\/\/doi.org\/10.3390\/ijms27177697","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,28]]}}}